Article
ITGB4 is a novel prognostic factor in colon cancer
1 Jan 2019
Abstract excerpt
Integrin β4 (ITGB4) has been reported to be involved in carcinomas. Currently, ITGB4 has been characterized in colon cancer, however, its clinical significance is not very clear. In the present study, we utilized the large public datasets from NCBI Gene Expression Omnibus (GEO) and The Cancer Genome Atlas (TCGA) databases and collected clinical samples in our center to investigate the transcriptional expressions...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
